Dr Reddy's launches drug for cancer patients

Our Bureau Hyderabad | Updated on May 10, 2011 Published on May 10, 2011

Dr Reddy's Laboratories Ltd has launched its fourth biologic drug, Peg-grafeel for cancer patients, in the domestic market.

Peg-grafeel, sold in pre-filled syringes, was approved in India to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy.

Neutropenia is the condition in which a patient has a lower than normal white blood cell count and is a common side effect of many chemotherapy regimens. The drug is priced at Rs 8,865. This is approximately 25 per cent of the originator brand in India and 95 per cent lower than the US price for pegfilgrastim, it claimed.

Published on May 10, 2011
This article is closed for comments.
Please Email the Editor